Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 14, Issue 11
|
pp. 4673–4698
CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma
Back to article
Figure 9
(9 of 9)
−
100%
+
Figure 9.
A schematic model of CXCR4 contributes distinctively to PI3K/Akt/mTOR pathway effects in EOC.
